Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Published in: European Journal of Clinical Microbiology & Infectious Diseases 7/2015

01-07-2015 | Article

Study of the diversity and short-chain fatty acids production by the bacterial community in overweight and obese Mexican children

Authors: S. Murugesan, M. Ulloa-Martínez, H. Martínez-Rojano, F. M. Galván-Rodríguez, C. Miranda-Brito, M. C. Romano, A. Piña-Escobedo, M. L. Pizano-Zárate, C. Hoyo-Vadillo, J. García-Mena

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 7/2015

Login to get access

Abstract

Obesity and overweight are health problems of multifactorial etiology, which may include changes in the microbiome. In Mexico, more than 30 % of the child population between 5 and 11 years of age suffer from being overweight or are obese, which makes it a public health issue in progress. The purpose of this work was to measure the short-chain fatty acid concentration by high-performance liquid chromatography (HPLC), and to characterize the bacterial diversity by ion torrent semiconductor sequencing, of 16S rDNA libraries prepared from stools collected from a sample of well-characterized Mexican children for normal weight, overweight, and obese conditions by anthropometric and biochemical criteria. We found that triglyceride levels are increased in overweight and obese children, who presented altered propionic and butyric acid concentrations in feces. In addition, although the colon microbiota did not show a clear bacterial dysbiosis among the three conditions, the abundance of some particular bacteria was changed with respect to normal controls. We conclude from our results that the imbalance in the abundance of at least nine different bacteria as well as altered short-chain fatty acid concentration in feces is associated to the overweight and obese conditions of Mexican children.
Appendix
Available only for authorised users
Literature
1.
2.
James WPT (2008) The epidemiology of obesity: the size of the problem. J Intern Med 263(4):336–352PubMedCrossRef
3.
Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C et al (2014) Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the global burden of disease study 2013. Lancet 384(9945):766–781PubMedCrossRef
4.
Holub CK, Elder JP, Arredondo EM, Barquera S, Eisenberg CM, Sánchez Romero LM et al (2013) Obesity control in Latin American and U.S. Latinos: a systematic review. Am J Prev Med 44(5):529–537PubMedCrossRef
5.
World Health Organization (WHO) (2008) The global burden of disease: 2004 update. WHO, Geneva, Switzerland
6.
Latnovic L, Rodriguez Cabrera L (2013) Public health strategy against overweight and obesity in Mexico’s national agreement for nutritional health. Int J Obes Supp 3:S12–S14CrossRef
7.
8.
Kannel WB, D’Agostino RB, Cobb JL (1996) Effect of weight on cardiovascular disease. Am J Clin Nutr 63(3 Suppl):419S–422SPubMed
9.
Carey VJ, Walters EE, Colditz GA, Solomon CG, Willett WC, Rosner BA et al (1997) Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses’ Health Study. Am J Epidemiol 145(7):614–619PubMedCrossRef
10.
11.
Devaraj S, Hemarajata P, Versalovic J (2013) The human gut microbiome and body metabolism: implications for obesity and diabetes. Clin Chem 59(4):617–628PubMedCentralPubMedCrossRef
12.
13.
14.
Caricilli AM, Castoldi A, Câmara NOS (2014) Intestinal barrier: a gentlemen’s agreement between microbiota and immunity. World J Gastrointest Pathophysiol 5(1):18–32PubMedCentralPubMedCrossRef
15.
Michelsen KS, Arditi M (2007) Toll-like receptors and innate immunity in gut homeostasis and pathology. Curr Opin Hematol 14(1):48–54PubMedCrossRef
16.
17.
Whelan K, Judd PA, Preedy VR, Taylor MA (2004) Enteral feeding: the effect on faecal output, the faecal microflora and SCFA concentrations. Proc Nutr Soc 63(1):105–113PubMedCrossRef
18.
Segain J-P, Raingeard de la Blétière D, Bourreille A, Leray V, Gervois N, Rosales C et al (2000) Butyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn’s disease. Gut 47:397–403
19.
Dengler F, Rackwitz R, Benesch F, Pfannkuche H, Gäbel G (2014) Both butyrate incubation and hypoxia upregulate genes involved in the ruminal transport of SCFA and their metabolites. J Anim Physiol Anim Nutr (Berl). doi:10.​1111/​jpn.​12201
20.
Clemente JC, Ursell LK, Parfrey LW, Knight R (2012) The impact of the gut microbiota on human health: an integrative view. Cell 148(6):1258–1270PubMedCrossRef
21.
Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A et al (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 101(44):15718–15723PubMedCentralPubMedCrossRef
22.
DiBaise JK, Zhang H, Crowell MD, Krajmalnik-Brown R, Decker GA, Rittmann BE (2008) Gut microbiota and its possible relationship with obesity. Mayo Clin Proc 83(4):460–469PubMedCrossRef
23.
24.
Gill SR, Pop M, DeBoy RT, Eckburg PB, Turnbaugh PJ, Samuel BS et al (2006) Metagenomic analysis of the human distal gut microbiome. Science 312(5778):1355–1359PubMedCentralPubMedCrossRef
25.
Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M et al (2005) Diversity of the human intestinal microbial flora. Science 308(5728):1635–1638PubMedCentralPubMedCrossRef
26.
27.
Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C et al (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464(7285):59–65PubMedCentralPubMedCrossRef
28.
Tremaroli V, Bäckhed F (2012) Functional interactions between the gut microbiota and host metabolism. Nature 489(7415):242–249PubMedCrossRef
29.
de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J (2007) Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 85(9):660–667PubMedCentralPubMedCrossRef
30.
Arimond M, Ruel MT (2004) Dietary diversity is associated with child nutritional status: evidence from 11 demographic and health surveys. J Nutr 134(10):2579–2585PubMed
31.
García Cuartero B, García Lacalle C, Jiménez Lobo C, González Vergaz A, Calvo Rey C, Alcázar Villar MJ et al (2007) Índice HOMA y QUICKI, insulina y péptido C en niños sanos. Puntos de corte de riesgo cardiovascular. An Pediatr (Barc) 66(5):481–490CrossRef
32.
Fierer N, Hamady M, Lauber CL, Knight R (2008) The influence of sex, handedness, and washing on the diversity of hand surface bacteria. Proc Natl Acad Sci U S A 105(46):17994–17999PubMedCentralPubMedCrossRef
33.
Whiteley AS, Jenkins S, Waite I, Kresoje N, Payne H, Mullan B et al (2012) Microbial 16S rRNA Ion Tag and community metagenome sequencing using the Ion Torrent (PGM) Platform. J Microbiol Methods 91(1):80–88PubMedCrossRef
34.
Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK et al (2010) QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7(5):335–336PubMedCentralPubMedCrossRef
35.
Edgar RC (2010) Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26(19):2460–2461PubMedCrossRef
36.
Haas BJ, Gevers D, Earl AM, Feldgarden M, Ward DV, Giannoukos G et al (2011) Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res 21:494–504PubMedCentralPubMedCrossRef
37.
DeSantis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, Keller K et al (2006) Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 72(7):5069–5072PubMedCentralPubMedCrossRef
38.
39.
De Baere S, Eeckhaut V, Steppe M, De Maesschalck C, De Backer P, Van Immerseel F et al (2013) Development of a HPLC-UV method for the quantitative determination of four short-chain fatty acids and lactic acid produced by intestinal bacteria during in vitro fermentation. J Pharm Biomed Anal 80:107–115PubMedCrossRef
40.
Samuel BS, Gordon JI (2006) A humanized gnotobiotic mouse model of host–archaeal–bacterial mutualism. Proc Natl Acad Sci U S A 103(26):10011–10016PubMedCentralPubMedCrossRef
41.
Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444(7122):1027–1031PubMedCrossRef
42.
Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK et al (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5(2):e9085PubMedCentralPubMedCrossRef
43.
44.
Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI (2009) The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 1(6):6ra14PubMedCentralPubMedCrossRef
45.
46.
47.
Wolever TMS, Spadafora P, Eshuis H (1991) Interaction between colonic acetate and propionate in humans. Am J Clin Nutr 53(3):681–687PubMed
48.
Vogt JA, Wolever TMS (2003) Fecal acetate is inversely related to acetate absorption from the human rectum and distal colon. J Nutr 133:3145–3148PubMed
49.
50.
Duncan SH, Belenguer A, Holtrop G, Johnstone AM, Flint HJ, Lobley GE (2007) Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol 73(4):1073–1078PubMedCentralPubMedCrossRef
51.
Gostner A, Blaut M, Schäffer V, Kozianowski G, Theis S, Klingeberg M et al (2006) Effect of isomalt consumption on faecal microflora and colonic metabolism in healthy volunteers. Br J Nutr 95(1):40–50PubMedCrossRef
52.
Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R et al (2014) Human genetics shape the gut microbiome. Cell 159:789–799PubMedCrossRef
53.
David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE et al (2014) Diet rapidly and reproducibly alters the human gut microbiome. Nature 505(7484):559–563PubMedCentralPubMedCrossRef
54.
Looft T, Johnson TA, Allen HK, Bayles DO, Alt DP, Stedtfeld RD et al (2012) In-feed antibiotic effects on the swine intestinal microbiome. Proc Natl Acad Sci U S A 109(5):1691–1696PubMedCentralPubMedCrossRef
55.
Truesdell SJ, Sims JC, Boerman PA, Seymour JL, Lazarus RA (1991) Pathways for metabolism of ketoaldonic acids in an Erwinia sp. J Bacteriol 173(21):6651–6656PubMedCentralPubMed
56.
Tims S, Derom C, Jonkers DM, Vlietinck R, Saris WH, Kleerebezem M et al (2013) Microbiota conservation and BMI signatures in adult monozygotic twins. ISME J 7(4):707–717PubMedCentralPubMedCrossRef
57.
Balamurugan R, George G, Kabeerdoss J, Hepsiba J, Chandragunasekaran AMS, Ramakrishna BS (2010) Quantitative differences in intestinal Faecalibacterium prausnitzii in obese Indian children. Br J Nutr 103(3):335–338PubMedCrossRef
58.
59.
Ravussin Y, Koren O, Spor A, LeDuc C, Gutman R, Stombaugh J et al (2012) Responses of gut microbiota to diet composition and weight loss in lean and obese mice. Obesity (Silver Spring) 20(4):738–747CrossRef
60.
Kameyama K, Itoh K (2014) Intestinal colonization by a lachnospiraceae bacterium contributes to the development of diabetes in obese mice. Microbes Environ. 2014 Oct 4. [Epub ahead of print]
61.
Zhao L (2013) The gut microbiota and obesity: from correlation to causality. Nat Rev Microbiol 11(9):639–647PubMedCrossRef
62.
Becker N, Kunath J, Loh G, Blaut M (2011) Human intestinal microbiota: characterization of a simplified and stable gnotobiotic rat model. Gut Microbes 2(1):25–33PubMedCrossRef
63.
Lee SM, Han HW, Yim SY (2015) Beneficial effects of soy milk and fiber on high cholesterol diet-induced alteration of gut microbiota and inflammatory gene expression in rats. Food Funct 6(2):492–500PubMedCrossRef
64.
Reichardt N, Duncan SH, Young P, Belenguer A, McWilliam Leitch C, Scott KP et al (2014) Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. ISME J 8(6):1323–1335PubMedCentralPubMedCrossRef
65.
Karlsson CLJ, Önnerfält J, Xu J, Molin G, Ahrné S, Thorngren-Jerneck K (2012) The microbiota of the gut in preschool children with normal and excessive body weight. Obesity 20:2257–2261PubMedCrossRef
66.
67.
Abdallah Ismail N, Ragab SH, Abd Elbaky A, Shoeib AR, Alhosary Y, Fekry D (2011) Frequency of Firmicutes and Bacteroidetes in gut microbiota in obese and normal weight Egyptian children and adults. Arch Med Sci 7(3):501–507PubMedCentralPubMedCrossRef
68.
Martinez-Marignac VL, Valladares A, Cameron E, Chan A, Perera A, Globus-Goldberg R et al (2007) Admixture in Mexico City: implications for admixture mapping of type 2 diabetes genetic risk factors. Hum Genet 120:807–819PubMedCrossRef
69.
Silva-Zolezzi I, Hidalgo-Miranda A, Estrada-Gil J, Fernandez-Lopez JC, Uribe-Figueroa L, Contreras A et al (2009) Analysis of genomic diversity in Mexican Mestizo populations to develop genomic medicine in Mexico. Proc Natl Acad Sci U S A 106:8611–8616PubMedCentralPubMedCrossRef
Metadata
Title
Study of the diversity and short-chain fatty acids production by the bacterial community in overweight and obese Mexican children
Authors
S. Murugesan
M. Ulloa-Martínez
H. Martínez-Rojano
F. M. Galván-Rodríguez
C. Miranda-Brito
M. C. Romano
A. Piña-Escobedo
M. L. Pizano-Zárate
C. Hoyo-Vadillo
J. García-Mena
Publication date
01-07-2015
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 7/2015
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-015-2355-4

Other articles of this Issue 7/2015

European Journal of Clinical Microbiology & Infectious Diseases 7/2015 Go to the issue

Article

Cystic echinococcosis in Bulgaria 1996–2013, with emphasis on childhood infections

Article

Evaluation of the BD BACTEC FX blood volume monitoring system as a continuous quality improvement measure

Article

Generic piperacillin/tazobactam is not associated with galactomannan false-positivity in adult patients with cancer: a case–control study

Article

Evaluation of several phenotypic methods for the detection of carbapenemase-producing Pseudomonas aeruginosa

Review

Unpredictable susceptibility of emerging clinical moulds to tri-azoles: review of the literature and upcoming challenges for mould identification

Article

Naturally occurring hepatitis B virus surface antigen mutant variants in Malaysian blood donors and vaccinees
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits